Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04494867 · ClinicalTrials.gov registry record · NA

Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation

A NA study of COVID-19, sponsored by Sharp HealthCare.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT04494867: Completed NA study of COVID-19, sponsored by Sharp HealthCare.

NCT04494867 is a NA study of COVID-19 that has completed, run by Sharp HealthCare. The registered enrollment target is 20 participants, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04494867, a NA study of COVID-19, has completed, sponsored by Sharp HealthCare.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of the proposed pilot study is to determine if core warming improves respiratory physiology of mechanically ventilated patients with COVID-19, allowing earlier weaning from ventilation, and greater overall survival.

Primary Outcome

Determine the change in PaO2/FiO2 ratio at 0, 24, 48, and 72 hours after implementation of core warming of ventilated patients, and compare this change to patients undergoing standard care.

Conditions Studied

Interventions

  • OTHER Standard of Care
  • DEVICE Core Warming

Study Locations (1)

California

  • Sharp Memorial Hospital - San Diego

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2020-08-19
Est. Completion 2022-02-28
Phase NA
Sharp HealthCare

32 total trials

What the finished NCT04494867 record still lists

NCT04494867 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 38,465-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower).

The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.

NCT04494867 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04494867 about?

NCT04494867 is a clinical study titled "Core Warming in COVID-19 Patients Undergoing Mechanical Ventilation". The purpose of the proposed pilot study is to determine if core warming improves respiratory physiology of mechanically ventilated patients with COVID-19, allowing earlier weaning from ventilation, and greater overall survival.

What is the current status of trial NCT04494867?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2020-08-19. Estimated completion is 2022-02-28.

What conditions does trial NCT04494867 study?

This clinical trial studies the following conditions: COVID-19.

What interventions are being tested in trial NCT04494867?

The interventions under investigation include: Standard of Care (OTHER), Core Warming (DEVICE).

Who is sponsoring clinical trial NCT04494867?

This trial is sponsored by Sharp HealthCare, which has 32 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04494867 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for COVID-19

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04494867's enrollment target sits among peer trials

20 279th of 298 higher than 14 of 298 other COVID-19 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04494867, the US trial registry maintained by the National Library of Medicine. NCT04494867 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.